Owlet (NYSE:OWLT – Get Free Report) and Profound Medical (NASDAQ:PROF – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Owlet and Profound Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
| Profound Medical | 1 | 0 | 1 | 1 | 2.67 |
Owlet presently has a consensus target price of $15.00, suggesting a potential upside of 261.01%. Profound Medical has a consensus target price of $11.50, suggesting a potential upside of 59.50%. Given Owlet’s higher probable upside, research analysts plainly believe Owlet is more favorable than Profound Medical.
Volatility & Risk
Owlet has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.
Profitability
This table compares Owlet and Profound Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Owlet | -8.61% | -601.24% | -15.96% |
| Profound Medical | -137.51% | -55.49% | -45.69% |
Valuation & Earnings
This table compares Owlet and Profound Medical”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Owlet | $105.70 million | 1.15 | -$39.68 million | ($0.75) | -5.54 |
| Profound Medical | $16.10 million | 16.37 | -$42.57 million | ($0.98) | -7.36 |
Owlet has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
72.6% of Owlet shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Owlet beats Profound Medical on 11 of the 15 factors compared between the two stocks.
About Owlet
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.
